Acute cardiac care & resuscitation

Prognostic Impact of Society for Cardiovascular Angiography and Interventions (SCAI) Shock Severity Classes in AMI-Related Cardiogenic Shock: A Sub-Study of the ECLS-SHOCK Trial

ESC Heart FailPublished sub-study of the ECLS-SHOCK trial

Authors' conclusion

In AMI-CS patients included in the ECLS-SHOCK trial, SCAI stages at admission were predictive for mortality and for the incidence of safety events. The efficacy of ECLS treatment was not affected by SCAI stage.

Study context

Population
Patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) enrolled in the ECLS-SHOCK trial between June 2019 and November 2022patients enrolled in the ECLS-SHOCK trial · SCAI Stage C 215 · SCAI Stage D 56 · SCAI Stage E 146
Participants
417 patients
Comparison
Outcomes, treatment effect and safety of ECLS stratified according to SCAI stage at admission
  • SCAI Stage Cn = 215
  • SCAI Stage Dn = 56
  • SCAI Stage En = 146
Methodological detailsmulticentre, randomized, post-hoc classification
  • Multicentre
  • Randomized
  • Post-hoc classification

Primary result

As reported in the abstract

30 day all-cause mortality · 30 day

Further findings

OutcomeValues
Renal replacement therapy · 30 daysSCAI Stage C 7.0% · SCAI Stage D 19.6% · SCAI Stage E 13.7%
Poor neurological outcomesSCAI Stage C 17.2% · SCAI Stage D 44.4% · SCAI Stage E 36.5%
  • Renal replacement therapy: P = 0.03
  • Poor neurological outcomes: P < 0.001

30 day all-cause mortality, ELCS vs. control by SCAI stage (subgroup)

SCAI C: ELCS vs. control
32.7% vs. 32.4%
SCAI D: ELCS vs. control
68.4% vs. 66.7%
SCAI E: ELCS vs. control
59.7% vs. 68.4%
No interaction was observed between SCAI stage and the treatment effect of ELCS on 30 day all-cause mortality
  • P for interaction = 0.65

Original publication

Prognostic Impact of SCAI Shock Severity Classes in AMI-Related Cardiogenic Shock: A Sub-Study of the ECLS-SHOCK Trial. ESC Heart Fail. Published 13 October 2025. doi:10.1002/ehf2.15446

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.